Publications by authors named "Saud AlHayli"

Claim this Profile
D
Definition, Diagnosis, Risk Stratification and Management of Newly Diagnosed Multiple Myeloma: The Saudi Myeloma Working Group Guidelines.
Ghazi S Alotaibi, Abdullah S Al Saleh, Ayman Alhejazi, Majed Alahmadi, Ibraheem Motabi, Saud Alhayli

Clin Lymphoma Myeloma Leuk· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle East.
Amr Hanbali, Ayman Saad, Syed Osman Ahmed, Mansour Alfayez, Heba Madien, Saud Alhayli

Clin Lymphoma Myeloma Leuk· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed death inhibitors in CNS B-cell lymphoma: A literature review.
Mostafa Mohammed Saleh, Walid Rasheed, Saud Alhayli, Alfadel Alshaibani, Mahmoud Aljurf

Blood Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle east.
Amr Hanbali, Fahad Bahkali, Farhatullah Syed, Ali Alahmari, Ahmad Alotaibi, Saud Alhayli

Cytotherapy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease Testing for Diffuse Large B Cell Lymphoma.
Miral Atout, Hadeel Elwaheidi, Rand Maarouf, Abdulwahab A Albabtain, Saud Alhayli

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group Guideline.
Ayman Alhejazi, Ghazi S Alotaibi, Abdullah S Al Saleh, Majed Alahmadi, Ibraheem Motabi, Saud Alhayli

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience.
Riad El Fakih, Taimoor Hussain, Oudai Sahwan, Ghaith Meir, Abdulwahab A Albabtain, Saud Alhayli

Clin Lymphoma Myeloma Leuk· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience.
Riad El Fakih, Mohamed I Sharif, Shaykhah Alotaibi, Abdulrahman Almujalli, Sara Samarkandi, Saud Alhayli

Bone Marrow Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon Entities, Uncommon Challenges: A Review of Rare Plasma Cell Disorders.
Amr Hanbali, Abdullah Alamer, Saud Alhayli

Hematol Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duodenal-type follicular lymphoma: comprehensive insights into disease characteristics and established treatment strategies.
Ahmed Alnughmush, Riad El Fakih, Ruah Alyamany, Nasir Bakshi, Saud Alhayli

Curr Opin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.
Ahmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, Hazaa Al Zahrani, Ruah Al Yamany, Saud Alhayli

Ann Saudi Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.
Riad El Fakih, Momen Nassani, Walid Rasheed, Amr Hanbali, Fahad Almohareb, Saud Alhayli

Transplant Cell Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.
Ahmed Kotb, Hazzaa Alzahrani, Ali Alahmari, Syed Osman Ahmed, Saud Alhayli

Cytotherapy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation".
Majed Altareb, Moheeb Al-Awwami, Feras Alfraih, Saud Alhayli, Syed Osman Ahmed

Bone Marrow Transplant· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients.
Riad El Fakih, Abdulwahab A Albabtain, Saud Alhayli, Khawlah Farhan, Walid Rasheed

Semin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia.
Amr Hanbali, Ahmed Kotb, Riad El Fakih, Feras Alfraih, Nahla Shihata, Saud Alhayli

Int J Hematol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic transplant compared to pediatric-inspired therapy for Philadelphia chromosome-negative adolescent and adult ALL in first complete remission.
Alfadil Haroon, Feras Alfraih, Amr Hanbali, Ahmed Kotb, Zakiah Al Somali, Saud Alhayli

Bone Marrow Transplant· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts.
Riad El Fakih, Feras Alfraih, Saud Alhayli, Syed Osman Ahmed, Marwan Shaheen

Ann Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full Dose Cyclophosphamide with the Addition of Fludarabine for Matched Sibling Transplants in Severe Aplastic Anemia.
Riad El Fakih, Saud Alhayli, Syed Osman Ahmed, Marwan Shaheen, Naeem Chaudhri

Transplant Cell Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East.
Riad El Fakih, Alfadil Haroon, Feras Alfraih, Murtadha K Al-Khabori, Mohsen Alzahrani, Saud Alhayli

Bone Marrow Transplant· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia.
Ahmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, Shahrukh Hashmi, Yasser Mohamed Khafaga, Saud Alhayli

Ann Saudi Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival in adolescents and young adults (AYA) patients aged 14-55 years with acute lymphoblastic leukemia using pediatric-inspired protocol - a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center.
Amr Hanbali, Ahmed Kotb, Riad El Fakih, Feras Alfraih, Syed Osman Ahmed, Saud Alhayli

Leuk Res Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalities.
Mona Hassanein, Riad El Fakih, Walid Rasheed, Syed Ahmed, Marwan Shaheen, Saud Alhayli

EJHaem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes.
Igor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, Ivan Pasic, Zeyad Al-Shaibani

Eur J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis